These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 26457076)
1. 15-Deoxy-Δ(12,14)-Prostaglandin J2 Inhibits Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury via Redox Pathway. Liu X; Jia S; Li W; Yang L; Yang L; Wang L; Li L PPAR Res; 2015; 2015():876160. PubMed ID: 26457076 [TBL] [Abstract][Full Text] [Related]
2. 15-deoxy-Δ Li W; Xie J; Yang L; Yang Y; Yang L; Li L Int Immunopharmacol; 2023 Aug; 121():110491. PubMed ID: 37329807 [TBL] [Abstract][Full Text] [Related]
3. miR-27b-3p, miR-181a-1-3p, and miR-326-5p are involved in the inhibition of macrophage activation in chronic liver injury. Li W; Chang N; Tian L; Yang J; Ji X; Xie J; Yang L; Li L J Mol Med (Berl); 2017 Oct; 95(10):1091-1105. PubMed ID: 28748390 [TBL] [Abstract][Full Text] [Related]
4. [Effect of 15-deoxy-Δ(12), 14-prostaglandin J2 on the cytokines in the culture supernatant of bone marrow mesenchymal stem cells]. Chi Y; DU WJ; Cui JJ; Chen F; Han ZB; Ma FX; Li X; Yang SG; Lu SH; Han ZC Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1557-62. PubMed ID: 24370048 [TBL] [Abstract][Full Text] [Related]
5. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms. Ray DM; Akbiyik F; Phipps RP J Immunol; 2006 Oct; 177(8):5068-76. PubMed ID: 17015690 [TBL] [Abstract][Full Text] [Related]
6. Bone-marrow-derived mesenchymal stem cells inhibit gastric aspiration lung injury and inflammation in rats. Zhou J; Jiang L; Long X; Fu C; Wang X; Wu X; Liu Z; Zhu F; Shi J; Li S J Cell Mol Med; 2016 Sep; 20(9):1706-17. PubMed ID: 27061967 [TBL] [Abstract][Full Text] [Related]
7. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2. Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591 [TBL] [Abstract][Full Text] [Related]
9. 15-Deoxy-Δ Yamamoto Y; Koma H; Yagami T Biol Pharm Bull; 2020; 43(1):153-157. PubMed ID: 31902920 [TBL] [Abstract][Full Text] [Related]
10. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells. Chen ZY; Tseng CC Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033 [TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of 15-deoxy Δ Yamamoto Y; Yamamoto T; Koma H; Nishii A; Yagami T Biochem Biophys Rep; 2017 Mar; 9():61-66. PubMed ID: 28955990 [TBL] [Abstract][Full Text] [Related]